Immucell (ICCC) Work In Process (2018 - 2026)
Immucell's (ICCC) quarterly Work In Process came in at $5.7 million in Q4 2025, little changed YoY from $5.7 million in Q4 2024, and down 3.42% on a QoQ basis from $6.0 million in Q3 2025.
Immucell (ICCC) Work In Process (2018 - 2026) Analysis & Trends
Immucell (ICCC) has 8 years of Work In Process data on file, last reported at $5.7 million in Q4 2025.
- Quarterly Work In Process changed 0.04% year-over-year to $5.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.7 million (changed 0.04% YoY) and the FY2025 annual result came in at $5.7 million, changed 0.04% from the prior year.
- Work In Process eased to $5.7 million in Q4 2025, from $6.0 million in the prior quarter.
- In the past five years, Work In Process ranged from a high of $6.1 million in Q3 2024 to a low of $1.4 million in Q1 2021.
- A 5-year average of $5.1 million and a median of $5.6 million in 2024 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2021 — Work In Process surged 69.55% — and 2025, when it slipped 2.81%.
- Tracing ICCC's Work In Process over 5 years: stood at $1.4 million in 2021, then surged by 142.14% to $3.5 million in 2022, then soared by 67.65% to $5.8 million in 2023, then retreated by 1.18% to $5.7 million in 2024, then gained by 0.04% to $5.7 million in 2025.
- The last three Work In Process figures came in at $5.7 million (Q4 2025), $6.0 million (Q3 2025), and $5.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.54 Mn |
| Dec 31, 2025 | 5.75 Mn |
| Sep 30, 2025 | 5.95 Mn |
| Jun 30, 2025 | 5.58 Mn |
| Mar 31, 2025 | 5.76 Mn |
| Dec 31, 2024 | 5.75 Mn |
| Sep 30, 2024 | 6.12 Mn |
| Jun 30, 2024 | 5.61 Mn |
| Mar 31, 2024 | 5.51 Mn |
| Dec 31, 2023 | 5.82 Mn |
| Sep 30, 2023 | 5.33 Mn |
| Jun 30, 2023 | 4.83 Mn |
| Dec 31, 2022 | 3.47 Mn |
| Mar 31, 2021 | 1.43 Mn |
| Dec 31, 2020 | 1.44 Mn |
| Sep 30, 2020 | 1.29 Mn |
| Jun 30, 2020 | 1.21 Mn |
| Mar 31, 2020 | 844,889.00 |
| Dec 31, 2019 | 1.21 Mn |
| Sep 30, 2019 | 1.14 Mn |